Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modeling.
Health care cost-effectiveness analysis (CEA) often uses individual patient data (IPD) from multinational randomized controlled trials. Although designed to account for between-patient sampling variability in the clinical and economic data, standard analytical approaches to CEA ignore the presence of between-location variability in the study results. This is a restrictive limitation given that countries often differ in factors that could affect the results of CEAs, such as the availability of health care resources, their unit costs, clinical practice, and patient case mix. The authors advocate the use of Bayesian bivariate hierarchical modeling to analyze multinational cost-effectiveness data. This analytical framework explicitly recognizes that patient-level costs and outcomes are nested within countries. Using real-life data, the authors illustrate how the proposed methods can be applied to obtain (a) more appropriate estimates of overall cost-effectiveness and associated measure of sampling uncertainty compared to standard CEA and (b) country-specific cost-effectiveness estimates that can be used to assess the between-location variability of the study results while controlling for differences in country-specific and patient-specific characteristics. It is demonstrated that results from standard CEA using IPD from multinational trials display a large degree of variability across the 17 countries included in the analysis, producing potentially misleading results. In contrast, "shrinkage estimates'' obtained from the modeling approach proposed here facilitate the appropriate quantification of country-specific cost-effectiveness estimates while weighting the results based on the level of information available within each country. The authors suggest that the methods presented here represent a general framework for the analysis of economic data collected from different locations.
Manca
Andrea
A
Centre for Health Economics, University of York, UK. am126@york.ac.uk
Lambert
Paul C
PC
Sculpher
Mark
M
Rice
Nigel
N
D001499:Bayes Theorem; D003362:Cost-Benefit Analysis; D003627:Data Interpretation, Statistical; D006801:Humans; D007391:International Cooperation; D017059:Models, Econometric; D015337:Multicenter Studies as Topic / Q000191:economics* / Q000706:statistics & numerical data*; D016032:Randomized Controlled Trials as Topic / Q000191:economics* / Q000706:statistics & numerical data*